If you’re building a pharmaceutical retargeting funnel, start with this principle:
Behavior drives the funnel. Not conditions.
This is where most pharma, medtech, and health tech teams go wrong. They rely on assumptions about who the user is, instead of understanding what the user actually does. That creates both compliance risks and weak performance.
A high-performing retargeting strategy for pharma brands is built on first-party behavioral signals — page visits, repeat engagement, and intent-driven actions. This approach aligns with HIPAA, GDPR, and regulatory requirements, while also improving relevance and conversion.
This guide breaks down how to build a compliant pharma marketing funnel that works in practice.
What Is a Pharmaceutical Retargeting Funnel?
A pharmaceutical retargeting funnel is a structured system that re-engages users based on their behavior across digital touchpoints.
Instead of targeting sensitive health data, it segments users based on:
- Pages they visited
- Frequency of engagement
- Content interactions
- Actions taken (or not completed)
The goal is to guide users through four stages:
Awareness → Consideration → Conversion → Retention
Each stage requires a different strategy, message, and channel mix.
Stage 1: Awareness (Top of Funnel)
At the awareness stage, users show low intent. They may have visited a homepage or general disease education content.
Audience:
- First-time visitors
- Users with low engagement signals
Messaging:
Focus on education, not promotion:
- “Learn more about managing symptoms”
- “Explore resources for [condition]”
Channels:
- Display (Google Display Network)
- Paid social (Meta platforms)
- Programmatic
Timing:
- – 1–7 days after visit
At this stage, your role is simple: inform without pressure.
Stage 2: Consideration (Mid Funnel)
At this stage, users show increasing intent through repeated engagement.
Audience:
- Multiple page visits
- Product page views
- Interaction with tools or guides
Messaging:
Introduce deeper, structured content:
- “How this treatment works” (mechanism of action)
- “Prepare for your next doctor visit”
Channels:
- LinkedIn (professional targeting)
- YouTube (MOA and educational video)
- Native content
Timing:
- 7–30 days after initial interaction
Here, your goal is to educate and build understanding.
Stage 3: Conversion (Bottom of Funnel)
Now the user shows high intent and is close to taking action.
Audience:
- Started but did not complete registration
- Clicked “find a provider”
- Engaged with savings or support pages
Messaging:
Focus on support and next steps:
- “Continue your registration”
- “Find a provider near you”
- “Access support options”
Channels:
- Search retargeting
- Email (with consent)
- Retargeting ads
Timing:
- Immediate (within hours or days)
At this stage, performance depends on one thing: removing friction.
Stage 4: Retention (Post-Conversion)
Retention is often underestimated — but it’s critical for long-term value.
Audience:
- Existing users
- Patients inactive for 60–90+ days
Messaging:
Focus on ongoing support and adherence:
- “Refill reminders”
- “Stay on track with your treatment”
- “Access ongoing support”
Channels:
- Push notifications
- CRM systems
Timing:
- Based on lifecycle and usage patterns
At this stage, performance depends on one thing: removing friction.
Compliance & Best Practices
Use behavior, not sensitive data:
Segment users based on actions, not diagnoses.
Align with regulations:
Ensure compliance with HIPAA (US), GDPR (EU), and local healthcare laws.
Include Important Safety Information (ISI):
Where required, integrate ISI clearly into creative assets.
Control frequency:
Use frequency capping to prevent fatigue and maintain trust.
Keep messaging educational:
Especially in early and mid stages.
Compliance is not a limitation. It’s a strategy.
Why Most Pharma Retargeting Funnels Fail
Most funnels underperform for predictable reasons:
- They push products too early
- They rely on sensitive targeting
- They ignore behavioral signals
- They lack stage-specific messaging
- They treat pharma like standard digital marketing
That approach doesn’t work.
Because healthcare decisions are different.
Final Thought
A pharmaceutical retargeting funnel is not just a performance tool.
It is a trust-building system.
When built correctly, it guides users from first interaction to long-term engagement — while staying fully compliant.
At Expansion 4YOU, we design retargeting strategies that balance performance, compliance, and trust.
Because in healthcare, that’s what drives results.
CTA
If you’re building or optimizing your pharmaceutical retargeting funnel,
this is where the right structure makes the difference.
Let’s talk.